Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis LM Byrne, FB Rodrigues, K Blennow, A Durr, BR Leavitt, RAC Roos, ... The Lancet Neurology 16 (8), 601-609, 2017 | 347 | 2017 |
Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis FB Rodrigues, JB Neves, D Caldeira, JM Ferro, JJ Ferreira, J Costa bmj 353, i1754, 2016 | 255 | 2016 |
Biological and clinical characteristics of gene carriers far from predicted onset in the Huntington's disease Young Adult Study (HD-YAS): a cross-sectional analysis RI Scahill, P Zeun, K Osborne-Crowley, EB Johnson, S Gregory, C Parker, ... The Lancet Neurology 19 (6), 502-512, 2020 | 160 | 2020 |
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington’s disease LM Byrne, FB Rodrigues, EB Johnson, PA Wijeratne, E De Vita, ... Science translational medicine 10 (458), eaat7108, 2018 | 151 | 2018 |
Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta … D Caldeira, FB Rodrigues, M Barra, AT Santos, D de Abreu, N Gonçalves, ... Heart 101 (15), 1204-1211, 2015 | 148 | 2015 |
Botulinum toxin type A therapy for cervical dystonia M Castelao, RE Marques, GS Duarte, FB Rodrigues, J Ferreira, ... The Cochrane database of systematic reviews 2017 (12), 2017 | 108 | 2017 |
Deep brain stimulation for dystonia FB Rodrigues, GS Duarte, D Prescott, J Ferreira, J Costa The Cochrane database of systematic reviews 2019 (1), 2019 | 90 | 2019 |
Neurofilament light protein in blood predicts regional atrophy in Huntington disease EB Johnson, LM Byrne, S Gregory, FB Rodrigues, K Blennow, A Durr, ... Neurology 90 (8), e717-e723, 2018 | 84 | 2018 |
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington’s disease FB Rodrigues, LM Byrne, R Tortelli, EB Johnson, PA Wijeratne, M Arridge, ... Science translational medicine 12 (574), eabc2888, 2020 | 81 | 2020 |
Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington’s disease FB Rodrigues, LM Byrne, P McColgan, N Robertson, SJ Tabrizi, ... PloS one 11 (9), e0163479, 2016 | 77 | 2016 |
Fifteen years of clinical trials in Huntington’s disease: A very low clinical drug development success rate AM Travessa, FB Rodrigues, TA Mestre, JJ Ferreira Journal of Huntington's disease 6 (2), 157-163, 2017 | 75 | 2017 |
Survival, mortality, causes and places of death in a European Huntington's disease prospective cohort FB Rodrigues, D Abreu, J Damásio, N Goncalves, L Correia‐Guedes, ... Movement disorders clinical practice 4 (5), 737-742, 2017 | 73 | 2017 |
Cerebrospinal fluid total tau concentration predicts clinical phenotype in Huntington's disease FB Rodrigues, L Byrne, P McColgan, N Robertson, SJ Tabrizi, BR Leavitt, ... Journal of neurochemistry 139 (1), 22-25, 2016 | 70 | 2016 |
Huntington’s Disease Clinical Trials Corner: February 2018 FB Rodrigues, EJ Wild Journal of Huntington's Disease 7 (1), 89, 2018 | 67 | 2018 |
Botulinum toxin type A versus anticholinergics for cervical dystonia M Castelão, RE Marques, J Ferreira, C Sampaio, AP Moore, J Costa Cochrane Database of Systematic Reviews, 2021 | 64 | 2021 |
Tetrabenazine versus deutetrabenazine for Huntington's disease: twins or distant cousins? FB Rodrigues, GS Duarte, J Costa, JJ Ferreira, EJ Wild Movement disorders clinical practice 4 (4), 582-585, 2017 | 63 | 2017 |
Huntington’s disease clinical trials corner: April 2020 FB Rodrigues, EJ Wild Journal of Huntington's disease 9 (2), 185-197, 2020 | 62 | 2020 |
Placebo and nocebo responses in restless legs syndrome: A systematic review and meta-analysis MA Silva, GS Duarte, R Camara, FB Rodrigues, RM Fernandes, D Abreu, ... Neurology 88 (23), 2216-2224, 2017 | 56 | 2017 |
Botulinum toxin type A therapy for cervical dystonia RE Marques, M Castelão, J Ferreira, C Sampaio, AP Moore, J Costa Cochrane Database of Systematic Reviews, 2020 | 51 | 2020 |
Botulinum toxin type A versus botulinum toxin type B for cervical dystonia GS Duarte, M Castelao, FB Rodrigues, RE Marques, J Ferreira, ... The Cochrane database of systematic reviews 2016 (10), 2016 | 49 | 2016 |